Fshd1 clinical trials

Explore recruiting fshd1 clinical trials.

Recruiting fshd1 studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Fshd1 trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1/2a Dose-Escalating Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ARO-DUX4 in Adult Patients With Facioscapulohumeral Muscular Dystrophy Type 1

Netherlands, Spain, Germany, Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, 48-Week, Parallel-Group Study of the Efficacy and Safety of Losmapimod in Treating Subjects with Facioscapulohumeral Muscular Dystrophy (FSHD) with Open-Label Extension (OLE)

Spain, France

Therapeutic exploratory (Phase II) EU CTIS Study details

An Open-Label Pilot Study of Losmapimod to Evaluate the Safety, Tolerability, and Changes in Biomarker and Clinical Outcome Assessments in Subjects With Facioscapulohumeral Muscular Dystrophy 1 (FSHD1) with Extension

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A bicentric, randomized, double blind, placebo-controlled pilot study to evaluate the efficacy and safety of satralizumab in FSHD1

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Fshd1 trials by city

Fshd1 in Toronto Fshd1 in Vancouver Fshd1 in Montreal Fshd1 in Calgary Fshd1 in Edmonton Fshd1 in Ottawa Fshd1 in Winnipeg Fshd1 in Quebec City Fshd1 in Hamilton Fshd1 in Kitchener Fshd1 in London Fshd1 in Halifax Fshd1 in New York Fshd1 in Los Angeles Fshd1 in Chicago Fshd1 in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease